FrancophonIA/ELRC3.0 huggingface dataset:
English: This dosage recommendation for lansoprazole corresponds with the last available Consensus Report of the European Helicobacter Pylori Study Group.
Slovenian: Ta priporočila v zvezi z odmerjanjem za lansoprazol se skladajo z zadnjim razpoložljivim poročilom o konsenzu Evropskega združenja za raziskave Helicobacter Pylori.
English: Lansoprazol ratiopharm 15 mg, 30 mg, gastro-resistant capsules, hard were referred for arbitration according to Article 29 of Council Directive 2001/83/EC, as amended, following concerns raised by Germany and Portugal during a Mutual Recognition Procedure with Finland acting as Reference Member state.
Slovenian: Zdravilo Lansoprazol ratipharm 15-mg, 30-mg gastrorezistentne kapsule, trde, je bilo napoteno na arbitražni postopek v skladu s členom 29 Direktive Sveta 2001/83/ES, kakor je bila spremenjena, zaradi zadržkov, ki sta jih predložili Nemčija in Portugalska v okviru postopka medsebojnega priznavanja s Finsko, ki je bila referenčna država članica.
English: Lansoprazol ratiopharm has minor or moderate influence on the ability to drive and use machines.
Slovenian: Lansopazol -Ratiopharm ima blag ali zmeren vpliv na sposobnost vožnje in upravljanja s stroji.
English: Portugal ratiopharm Lda, Portugal Edifício Tejo, 6º piso Rua Quinta do Pinheiro 2790-143 Carnaxide Portugal
Slovenian: Portugalska ratiopharm Lda, Portugal Edifício Tejo, 6º piso Rua Quinta do Pinheiro 2790-143 Carnaxide Portugalska
English: Metronidazole was originally considered as an alternative to amoxicillin but there is now tendency to reserve it for rescue therapy in the case of a first eradication failure.
Slovenian: Metronidazol je bil prvotno mišljen kot alternativa za amoksicilin, vendar pa se čedalje bolj uveljavlja kot rešilno zdravljenje v primeru, ko je zdravljenje prve izbire neuspešno.
English: Important information about some of the ingredients of Lansoprazol-ratiopharm This medicine contains sucrose.
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila Lansoprazol-ratiopharm To zdravilo vsebuje saharozo.
English: The appropriate dosing will be possible with 30 mg capsules as well as with 15 mg capsules and therefore, a risk to public health with the use of the 15 mg strength for eradication therapy is not seen.
Slovenian: Ustrezno odmerjanje bo možno tako z 30 mg kapsulo kot s 15 mg kapsulami, zato tveganj za javno zdravje pri uporabi 15 mg jakosti za eradikacijsko zdravljenje ni videti.
English: If you have the impression that the effect of Lansoprazol-ratiopharm is too strong or too weak, please talk to your doctor.
Slovenian: Če menite, da je učinek zdravila Lansoprazol-ratiopharm premočan ali prešibak, se posvetujte z zdravnikom.
English: Like all medicines, Lansoprazol-ratiopharm can cause side effects, although not everybody gets them.
Slovenian: Kot vsa zdravila ima lahko tudi zdravilo Lansoprazol-ratiopharm neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
English: If you forget to take Lansoprazol-ratiopharm Do not take a double dose to make up for a forgotten dose.
Slovenian: Če ste pozabili vzeti zdravilo Lansoprazol-ratiopharm Ne vzemite dvojnega odmerka, če ste pozabili vzeti prejšnji odmerek.
English: Lansoprazol-ratiopharm should be taken on an empty stomach (before meals).
Slovenian: Zdravilo Lansoprazol-ratiopharm morate jemati na prazen želodec (pred obroki).
English: In patients with cirrhosis theAUC of lansoprazole is significantly increased and the elimination half-life is prolonged, but no signs of accumulation of lansoprazole have been detected.
Slovenian: Pri bolnikih s cirozo je vrednost AUC lansoprazola bistveno povečana, razpolovni čas izločanja je podaljšan, vendar znakov kopičenja lansoprazola niso odkrili.
English: Lansoprazol-ratiopharm capsules are swallowed whole with sufficient liquid (e.g. a glass of water).
Slovenian: Kapsule Lansoprazol-ratiopharm je treba pogoltniti cele, z zadostno količino vode (npr. s kozarcem vode).
English: Austria ratiopharm Arzneimittel Vertriebs -GmbH Albert-Schweitzer-G. 3 1140 Vienna Austria
Slovenian: Avstrija ratiopharm Arzneimittel Vertriebs -GmbH Albert-Schweitzer-G. 3 1140 Dunaj
English: Lansoprazol-ratiopharm is a medicine which reduces the amount of acid made by the stomach (selective proton pump inhibitor).
Slovenian: Lansoprazol-ratiopharm je zdravilo, ki zmanjša količino kisline, ki jo izloča želodec (selektivni zaviralec protonske črpalke).
English: If you take more Lansoprazol-ratiopharm than you should you should always consult a doctor.
Slovenian: Če ste vzeli večji odmerek zdravila Lansoprazol-ratiopharm, kot bi smeli: vedno se posvetujte z zdravnikom.
English: If you take too low a dose, if you take your medicine irregularly or if you stop your treatment prematurely, this may endanger the success of your treatment or may cause relapses which are more difficult to treat.
Slovenian: Če ste prenehali jemati zdravilo Lansoprazol-ratiopharm Če ste vzeli premajhen odmerek, če zdravilo jemljete neredno ali če prezgodaj prekinete zdravljenje, lahko ogrozite uspeh zdravljenja ali povzročite ponovitve, ki se zdravijo težje.
English: Taking Lansoprazol-ratiopharm with food and drink:
Slovenian: Jemanje zdravila Lansoprazol-ratiopharm skupaj s hrano in pijačo:
English: The risk/benefit ratio of Lansoprazol ratiopharm 15 mg, 30 mg is considered to be favourable provided that appropriate information regarding H. pylori eradication therapy are included in the SPC.
Slovenian: Razmerje med tveganji in koristmi za zdravilo Lansoprazol ratipharm 15 mg, 30 mg velja za ugodno pod pogojem, da se ustrezni podatki v zvezi z zdravljenjem za eradikacijo H. pylori vključijo v Povzetek glavnih značilnosti zdravila.
English: Do not use Lansoprazol-ratiopharm after the expiry date which is stated on the carton and the blister.
Slovenian: Zdravila Lansoprazol-ratiopharm ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatlici ali pretisnem omotu.
English: The effect of Lansoprazol-ratiopharm may be influenced by the following medicines or drug groups:
Slovenian: Na učinek zdravila Lansoprazol-ratiopharm lahko vplivajo naslednja zdravila ali skupine zdravil
English: The recommended dosage can be fulfilled by administering one capsule of 30 mg or two capsules of 15 mg twice daily, because the composition of the content of one capsule with 30 mg lansoprazole is exactly the same as the composition of the content of two capsules with 15 mg lansoprazole, as “Description and Composition of the Drug Product” (3.2.P1) of both strengths show
Slovenian: Priporočen odmerek je izpolnjen z dajanjem ene 30 mg kapsule ali dveh 15 mg kapsul dvakrat dnevno, kajti sestava ene kapsule s 30 mg lansoprazola je popolnoma enaka sestavi dveh kapsul s 15 mg lansoprazola, kakor je razvidno iz »Opisa in sestave zdravila (3.2.P1)« za obe jakosti.
English: It is recommended that you take Lansoprazol-ratiopharm before meals, as simultaneous food intake reduces the availability of lansoprazole to the body.
Slovenian: Zdravilo Lansoprazol-ratiopharm je priporočeno jemati pred obroki, ker sočasno uživanje hrane zmanjša uporabnost lansoprazola v telesu.
English: NAME OF THE MARKETING AUTHORISATION HOLDER ratiopharm GmbH [see Annex I - to be completed nationally]
Slovenian: IME IMETNIKA DOVOLJENJA ZA PROMET ratiopharm GmbH [Glejte Dodatek I - podatke je treba dopolniti v posameznih državah]
English: “How to take Lansoprazol-ratiopharm”) - if you use Lansoprazol-ratiopharm in combination therapy with antibiotics to eradicate Helicobacter pylori, you should carefully read the package leaflets of these antibiotics, too - if you take Lansoprazol-ratiopharm for longer than 1 year, therapy should be regularly monitored and the doctor should carefully consider the benefit versus risk ratio - if you experience any problems with your eyesight following long-term use (longer than 1 year), treatment with Lansoprazol-ratiopharm should be promptly discontinued and you should consult an ophthalmologist.
Slovenian: "Kako jemati zdravilo Lansoprazol ratiopharm"),- če zdravilo Lansoprazol-ratiopharm uporabljate skupaj z antibiotiki pri kombiniranem zdravljenju za odstranitev bakterije Helicobacter pylori, morate pozorno prebrati tudi navodila za uporabo teh antibiotikov, - če zdravilo Lansoprazol-ratiopharm jemljete več kot eno leto, mora zdravnik redno nadzirati zdravljenje ter oceniti koristi in tveganje, - če po dolgotrajnem zdravljenju (daljšem od 1 leta) z zdravilom Lansoprazol-ratiopharm opazite težave z vidom, morate zdravljenje nemudoma prekiniti in se posvetovati z okulistom.
English: What Lansoprazol-ratiopharm is and what it is used for Before you take Lansoprazol-ratiopharm How to take Lansoprazol-ratiopharm Possible side effects
Slovenian: Kaj je zdravilo Lansoprazol-ratiopharm in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Lansoprazol-ratiopharm Kako jemati zdravilo Lansoprazol-ratiopharm Možni neželeni učinki
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF LANSOPRAZOL RATIOPHARM 15 MG, 30 MG, GASTRO-RESISTANT CAPSULES, HARD (see Annex I)
Slovenian: SPLOŠNI POVZETEK ZNANSTVENEGA VREDNOTENJA ZDRAVILA LANSOPRAZOL RATIOPHARM 15 MG, 30 MG, GASTROREZISTENTNE KAPSULE, TRDE (glejte Dodatek I)
English: The concerns rose referred to discrepancies in comparison to the reference products on posology triple therapy for H. pylori eradication and indication of the 15 mg dosage form.
Slovenian: Zadržki so bili predloženi zaradi neskladnosti pri primerjavi z referenčnimi zdravili v zvezi z odmerjanjem v tritirni terapiji za eradikacijo H.pylori ter navedbe oblike 15 mg odmerka.
English: Lansoprazol-ratiopharm is not recommendes for use in children, as its safety and efficacy have not been established in this patient group.
Slovenian: Zdravilo Lansoprazol-ratiopharmRATIOPHARM ne priporočamo za uporabo pri otrocih, ker v tej skupini bolnikov njegova varnost in učinkovitost nista bili potrjeni.
English: - Before treatment with Lansoprazol-ratiopharm - the diagnosis of ulcers of the duodenum or stomach and inflammation of the gullet due to reflux of stomach acid should be confirmed by gastroscopy or other appropriate diagnostic measures (e.g. X-ray with contrast media) - a stomach ulcer with Lansoprazol-ratiopharm, the possibility of a malignant stomach tumour should be excluded.
Slovenian: - Pred zdravljenjem z zdravilom Lansoprazol-ratiopharm - diagnozo razjed dvanajstnika ali želodca in vnetje požiralnika zaradi refluksa želodčne kisline je treba potrditi z gastroskopijo ali drugo ustrezno diagnostično metodo (npr. rentgenskim slikanjem s kontrastnim sredstvom) - pred zdravljenjem želodčne razjede z zdravilom Lansoprazol-ratiopharm je treba izključiti možnost obstoja malignega tumorja na želodcu.
English: When making a decision as to whether breastfeeding or therapy with Lansoprazol-ratiopharm should be continued or discontinued, the benefits of breastfeeding for the child and the benefits of therapy with Lansoprazol-ratiopharm for the mother should be considered.
Slovenian: Pri odločitvi, ali je treba dojenje ali zdravljenje z zdravilom Lansoprazol-ratiopharm nadaljevati ali prekiniti, je treba upoštevati koristi dojenja za otroka in koristi zdravljenja z zdravilom Lansoprazolratiopharm za mater.
English: Patients with severely impaired liver function should not take Lansoprazol-ratiopharm, nor should they be given combination therapy with clarithromycin.
Slovenian: Bolniki s hudo okvaro delovanja jeter ne smejo jemati zdravila Lansoprazol-ratiopharm niti ne smejo biti podvrženi kombiniranemu zdravljenju s klaritromicinom.
English: At the beginning or end of simultaneous use of Lansoprazol-ratiopharm, plasma tacrolimus concentrations should be monitored.
Slovenian: Na začetku in koncu sočasne uporabe zdravila Lansoprazol-ratiopharm je treba nadzorovati koncentracijo takrolimusa v plazmi.
English: Fluvoxamine (a medicine for the treatment of depression), ketoconazole and itraconazole (medicines for the treatment of fungal infections), protease inhibitors (active substances used in the treatment of the AIDS virus) and macrolides (certain types of antibiotics) may markedly raise the concentration of lansoprazole in the blood and thus increase the effect of Lansoprazol-ratiopharm.
Slovenian: Fluvoksamine (zdravilo za zdravljenje depresije), ketokonazol in itrakonazol (zdravili za zdravljenje glivičnih okužb), zaviralci proteaze (zdravilne učinkovine za zdravljenje okužbe z virusom AIDS) in makrolidi (vrsta antibiotikov) lahko znatno povečajo koncentracijo lansoprazola v krvi tako povečajo učinek zdravila Lansoprazol-ratiopharm.
English: Use of Lansoprazol-ratiopharm is not recommended during pregnancy.
Slovenian: Uporaba zdravila Lansoprazol-ratiopharm med nosečnostjo ni priporočena.
English: There is no need and it is not planned to reduce the dosage to 15 mg 2 times daily.
Slovenian: Zmanjšanje odmerka na 15 mg dvakrat dnevno ni potrebno niti ni načrtovano.
English: BEFORE YOU TAKE Lansoprazol-ratiopharm Do not take Lansoprazol-ratiopharm - if you are allergic (hypersensitive) to Lansoprazol or any of the other ingredients of Lansoprazol-ratiopharm.
Slovenian: KAJ MORATE VEDETI, PREDEN BOSTE VZELI ZDRAVILO Lansoprazol-ratiopharm Ne jemljite zdravila Lansoprazol-ratiopharm - če ste alergični na (preobčutljivi za) lansoprazol ali katerokoli sestavino zdravila Lansoprazol-ratiopharm.
English: Lansoprazol-ratiopharm may not be used in children, as its safety and efficacy have not been established in this patient group.
Slovenian: Otroci ne smejo uporabljati zdravila Lansoprazol-ratiopharm, ker v tej skupini bolnikov njegova varnost in učinkovitost nista bili potrjeni.
English: Lansoprazol-ratiopharm is given:
Slovenian: Lansoprazol-ratiopharm se uporablja:
English: Intake of Lansoprazol-ratiopharm may mask the symptoms of a tumour and delay diagnosis of this condition
Slovenian: Jemanje zdravila Lansoprazol-ratiopharm lahko zakrije znake tumorja in prepreči pravočasno diagnosticiranje te bolezni
English: Ketoconazole and itraconazole (medicines for the treatment of fungal infections) The combination of lansoprazole and ketoconazole or itraconazole should be avoided, as the reduction in stomach acid caused by intake of Lansoprazol-ratiopharm may impair the absorption of the other medicines into the blood, thus leading to an underdose.
Slovenian: Ketokonazol in itrakonazol (zdravili za zdravljenje glivičnih okužb) Kombinaciji lansoprazola in ketokonazola ali itrakonazola se je treba izogibati, ker zmanjšanje količine želodčne kisline pri jemanju zdravila Lansoprazol-ratiopharm lahko poslabša absorpcijo drugih zdravil v kri in tako povzroči zmanjšanje odmerka.
English: Reduction of the clarithromycin dose in the clarithromycin-metronidazole combination is supported by clinical data as well as the Maastricht Consensus Report, stating that 250 mg dose is sufficient even if the recommended dose is 500 mg.
Slovenian: Zmanjšanje odmerka klaritromicina v kombinaciji klaritromicin-metronidazol podpirajo tako klinični podatki kot poročilo o konsenzu iz Maastrichta, ki navaja, da odmerek 250 mg zadostuje , kljub temu da je priporočen odmerek 500 g. Vendar pa poročilo z 2. konsenz konference v Maastrichtu ne podpira zmanjšanja odmerka klaritromicina na 250 mg v tritirnem zdravljenju, kjer je odmerek amoksiklicina 1000 mg.
English: Co-administration of lansoprazole increases the plasma concentrations of tacrolimus (a CYP3A and Pgp substrate).
Slovenian: Takrolimus Sočasna uporaba z lansoprazolom poveča koncentracijo takrolimusa (substrat encimov CYP3A in P
English: Eradication of H. pylori and peptic ulcer healing (posology) In order to standardise the treatment regimens for H. pylori eradication guidelines on the management of Helicobacter pylori infection were published by the European Helicobacter pylori Study Group.
Slovenian: Z namenom, da bi standardizirali terapevtske sheme za eradikacijo bakterije H.pylori, je Evropsko združenje za raziskave Helicobacter pylori objavilo smernice o obvladovanju okužbe z Helicobacter pylori.
English: You should avoid breastfeeding while taking Lansoprazol-ratiopharm, as there has been insufficient experience with its use during lactation.
Slovenian: Med jemanjem zdravila Lansoprazol-ratiopharm se morate izogibati dojenju, ker so izkušnje z njegovo uporabo med dojenjem omejene.
English: Eradication of H. pylori and peptic ulcer healing (15 mg dosage form) According to the proposed SmPC (> day 60), section 4.2, the recommended dose for H. pylori eradication is 30 mg twice daily.
Slovenian: V skladu s predlaganim SmPC (>60 dni), razdelek 4.2., je predlagan odmerek za eradikacijo H. pylori 30 mg dvakrat dnevno.
English: WHAT Lansoprazol-ratiopharm IS AND WHAT IT IS USED FOR
Slovenian: KAJ JE ZDRAVILO Lansoprazol-ratiopharm IN ZA KAJ GA UPORABLJAMO
English: INFORMATION IN BRAILLE < Lansoprazol-ratiopharm 15 mg > [to be completed nationally]
Slovenian: PODATKI V BRAILLOVI PISAVI Lansoprazol-ratiopharm 15 mg [Podatke je treba dopolniti v posameznih državah]
English: INFORMATION IN BRAILLE < Lansoprazol-ratiopharm 30 mg > [to be completed nationally]
Slovenian: PODATKI V BRAILLOVI PISAVI Lansoprazol-ratiopharm 30 mg [Podatke je treba dopolniti v posameznih državah]
English: Treatment with Lansoprazol-ratiopharm therefore leads to a slightly increased risk of infections in the gastrointestinal tract, such as with salmonella and Campylobacter.
Slovenian: Zdravljenje z zdravilom Lansoprazol-ratiopharm zato nekoliko poveča tveganje okužb prebavil, kot so okužbe s salmonelo in bakterijo Campylobacter.
English: During treatment with Lansoprazol-ratiopharm, side effects such as light-headedness and fatigue may occur (see section 4.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Med zdravljenjem z zdravilom Lansoprazol-ratiopharm se lahko pojavijo stranski učinki, kot sta omotica in utrujenost (glejte poglavje 4 "Možni neželeni učinki").
English: the CHMP has recommended the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Lansoprazol ratiopharm and associated names (see Annex I).
Slovenian: ¾ so bili Povzetek glavnih značilnosti zdravila, označevanje in navodila za uporabo, ki jih je predlagal vlagatelj, ovrednoteni na podlagi predložene dokumentacije in znanstvene razprave znotraj Odbora, je CHMP za Lansoprazol ratiopharm in povezana imena (glejte Dodatek I), za katere so Povzetki glavnih značilnosti zdravila, označevanje in navodila za uporabo opredeljeni v Dodatku III, priporočil odobritev dovoljenj za promet.
English: What Lansoprazol-ratiopharm looks like and contents of the pack
Slovenian: Izgled zdravila Lansoprazol-ratiopharm in vsebina pakiranja
English: hydroxy sulphone, 5-hydroxy sulphide and 5-hydroxy lansoprazole.
Slovenian: V urinu so odkrili tri presnovke: 5-hidroksisulfon, 5-hidroksisulfid in 5-hidroksilansoprazol.
English: < Lansoprazol ratiopharm and associated names (see Annex I) 15 mg gastro-resistant hard capsules > < Lansoprazol ratiopharm and associated names (see Annex I) 30 mg gastro-resistant hard capsules >
Slovenian: < Lansoprazol -ratiopharm in povezana imena (glejte Dodatek I) 15 mg gastrorezistentne trde kapsule> < Lansoprazol -ratiopharm in povezana imena (glejte Dodatek I) 30 mg gastrorezistentne trde kapsule>
English: GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET Whereas, ¾ The scope of the referral was to agree on a harmonised the dosing schedule for triple therapy for eradication therapy for H. pylori.
Slovenian: ¾ je bil namen napotitve uskladiti shemo odmerjanja pri tritirni terapiji za zdravljenje za eradikacijo H. pylori.
English: Always take Lansoprazol-ratiopharm exactly as your doctor has told you.
Slovenian: Pri jemanju zdravila Lansoprazol-ratiopharm natančno upoštevajte zdravnikova navodila.
English: HOW TO TAKE Lansoprazol-ratiopharm
Slovenian: KAKO JEMATI ZDRAVILO Lansoprazol-ratiopharm
English: Take special care with Lansoprazol-ratiopharm
Slovenian: Bodite posebno pozorni pri uporabi jemanju zdravila Lansoprazol-ratiopharm
English: Marketing Authorisation Holder: ratiopharm GmbH, Graf-Arco-Strasse 3, D-89079 Ulm, Germany
Slovenian: Imetnik dovoljenja za promet z zdravilom: ratiopharm GmbH, Graf-Arco-Strasse 3, D-89079 Ulm, Nemčija
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-ratiopharm and associated names (see Annex I) 15 mg magensaftresistente Hartkapseln > [see Annex I - to be completed nationally]
Slovenian: Lansoprazol-ratiopharm in povezana imena (glejte Dodatek I) 15 mg trde gastrorezistentne kapsule [Glejte Dodatek I - podatke je treba dopolniti v posameznih državah]
English: How to store Lansoprazol-ratiopharm Further information
Slovenian: Shranjevanje zdravila Lansoprazol-ratiopharm Dodatne informacije
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-ratiopharm and associated names (see Annex I) 30 mg magensaftresistente Hartkapseln >
Slovenian: IME ZDRAVILA Lansoprazol-ratiopharm in povezana imena (glejte Dodatek I) 30 mg trde gastrorezistentne kapsule
English: What Lansoprazol-ratiopharm contains
Slovenian: Kaj vsebuje zdravilo Lansoprazol-ratiopharm
English: < Lansoprazol-ratiopharm and associated names (see Annex I) 30 mg magensaftresistente Hartkapseln > Lansoprazol
Slovenian: Lansoprazol-ratiopharm in povezana imena (glejte Dodatek I) 30 mg trde gastrorezistentne kapsule lansoprazol
English: < Lansoprazol-ratiopharm and associated names (see Annex I) 15 mg magensaftresistente Hartkapseln > Lansoprazol
Slovenian: Lansoprazol-ratiopharm in povezana imena (glejte Dodatek I) 15 mg, trde gastrorezistentne kapsule lansoprazol
English: changes in liver enzyme values.
Slovenian: Bolezni jeter in žolčnika Občasni: spremembe ravni jetrnih encimov.
English: ratiopharm GmbH Graf-Arco-Strasse 3 D-89070 Ulm Germany
Slovenian: ratiopharm GmbH GrafArcoStrasse 3 D-89070 Ulm Nemčija
English: Sweden ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Slovenian: Švedska ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Nemčija
English: Lantrolix 30 mg enterokapsler, hårde
Slovenian: Lantrolix 30 mg enterokapsler, hĺrde 30 mg
English: Italy ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Slovenian: Italija ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Nemčija
English: Luxembourg ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Slovenian: Luksemburg ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Nemčija
English: Denmark ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Slovenian: Danska ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Nemčija
English: Please consult your doctor before taking Lansoprazol-ratiopharm if you know that you are intolerant to certain sugars.
Slovenian: Če veste, da nekaterih sladkorjev ne prenašate, se pred jemanjem zdravila Lansoprazol-ratiopharm posvetujte z zdravnikom.
English: Monitoring of tacrolimus plasma concentrations is advised when concomitant treatment with lansoprazole is initiated or ended.
Slovenian: Uporaba lansoprazola lahko poveča povprečno izpostavljenost takrolimusu za do 81 %.Ob začetku in koncu sočasnega zdravljenja z lansoprazolom se priporoča nadzorovanje koncentracije takrolimusa v plazmi.
English: It is available in all European Member States.
Slovenian: Na voljo je v vseh državah članicah Evropske unije.
English: Zometa has been authorised since March 2001.
Slovenian: Zdravilo Zometa je odobreno od marca 2001.
English: The full European Public Assessment Report for Zometa can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila Zometa je na voljo na spletni strani agencije ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: The Committee also had concerns regarding the reliability of the data collected during the study.
Slovenian: Izrazil je tudi zadržke v zvezi z zanesljivostjo podatkov, zbranih med študijo.
English: The study was ‘open label': both the doctor and the patient knew which treatment they were using.
Slovenian: Študija je bila „odprta“: zdravnik in bolnica sta vedela, katero zdravilo se uporablja.